Vascular medicine

Dr David Cabrera

David is currently working to engineer magnetic nanoparticles (MNPs) as a new platform to treat venous thromboembolism (VTE). VTE is a condition in which unwanted blood clots formed in leg veins travel through the bloodstream and lodge in the lungs, which may lead to death and important disabilities.

Dr Ruoli Chen

Ruoli’s research interests include hypoxia biology, stroke medicine and blood brain barriers. In particular, his work focuses on pharmacological activation of hypoxia inducible factor pathways in stroke therapy and prevention.

Dr Scott Guimond

Scott's work takes advantage of the diversity of structure within heparin and heparin-like molecules to develop potential therapeutics to improve wound healing and reduce blood vessel formation in diseases such as cancer.

Dr Alan Harper

Alan’s research interest focus on the molecular and cellular events that underlie human blood clotting, and how these become dysfunctional in acute cardiovascular disease.

Dr Sarah Hart

Sarah’s work is focused on finding analytical solutions to biological problems. Her group is interested in proteomics approaches to investigating various biological phenomena and diseases.

Dr Szu Shen Wong

Szu's research interest are predominantly in thrombosis and haemostasis with a focus on coagulation factors – specifically coagulation factor XI.